Clinical trial
Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder…
NCT00237289 · Ortho-McNeil Neurologics, Inc., Industry · Completed
Key facts
| NCT number | NCT00237289 |
|---|---|
| Title | Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting |
| Official title | Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting |
| Lead sponsor | Ortho-McNeil Neurologics, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 287 |
| Start date | Oct 1, 2001 |
| Completion | Oct 1, 2003 |
| First posted | Oct 12, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: